Guardian Pharmacy Services, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Guardian Pharmacy Services, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every $100 of sales, $2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $3 tied up three years earlier. Less money tied up than 89% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 14.0 times by its yearly operating cash. Higher than 87% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 4.5 times. Higher than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
4.5×Over the last 3 years its own operating cash covered its investment spending (capex) 4.5 times.
Higher than 85% of Healthcare companies in United States.
Cash Locked Ratio
$2For every $100 of sales, $2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $3 tied up three years earlier.
Less money tied up than 89% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$3Sales grew 59% in 3 years; of every extra $100 of sales, $3 became extra profit.
Lower than 65% of Healthcare companies in United States.
Asset Productivity Ratio
+59% / +61%In 3 years sales changed by +59% while total assets changed by +61%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
14.0×Debt due within a year is covered 14.0 times by its yearly operating cash.
Higher than 87% of Healthcare companies in United States.
Cash Cushion Ratio
+1%Cash, after subtracting all debt, equals 1% of its market value (net cash).
Lower than 66% of Healthcare companies in United States.
Tangible Assets Ratio
76%Of every $100 the company owns, $76 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 56% of Healthcare companies in United States.
Tangible Net Worth Ratio
52%Of every $100 of net worth, $52 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 52% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Guardian Pharmacy Services, Inc. owes $0.42 for every $1 it owns. Guardian Pharmacy Services, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
38.3Investors pay $38.3 for every $1 of Guardian Pharmacy Services, Inc.'s yearly profit, higher than 69% of Healthcare companies in United States.
P/B ratio
10.17The share price is 10.17 times Guardian Pharmacy Services, Inc.'s book value per share, higher than 87% of Healthcare companies in United States.
Market cap
$2.5 BThe total market value of all of Guardian Pharmacy Services, Inc.'s shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$246 MWhat Guardian Pharmacy Services, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.88Net worth divided by the number of shares. The share price of $39.44 is 10.2 times this, which is the P/B above.
Return on equity (ROE)
30.4%Guardian Pharmacy Services, Inc. earned 30.4% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
Owes vs Owns
0.42×Guardian Pharmacy Services, Inc. owes $0.42 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Dividend yield
NoneGuardian Pharmacy Services, Inc. does not currently pay a dividend.
Revenue growth
+18%Revenue rose 18% in the year to Dec 2025, and grew 17% a year on average over 3 years.
Profit growth
Back to profitGuardian Pharmacy Services, Inc. returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
3.4%Guardian Pharmacy Services, Inc. keeps $3 of every $100 of revenue as net profit.
Cash quality
2.0×Cash from Guardian Pharmacy Services, Inc.'s business was 2.0× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
109.3×Guardian Pharmacy Services, Inc.'s operating profit covered its interest costs 109.3 times in the year to Dec 2025.
Cash vs debt
Net cashGuardian Pharmacy Services, Inc. held $28 M more cash than debt (net cash) at Dec 2025.
Questions
What is Guardian Pharmacy Services, Inc.'s P/E ratio?
Investors pay $38.3 for every $1 of Guardian Pharmacy Services, Inc.'s yearly profit, higher than 69% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Guardian Pharmacy Services, Inc.: $2.5 B ÷ $246 M (30 Jun 2026) = 10.2.
What is Guardian Pharmacy Services, Inc.'s return on equity?
Guardian Pharmacy Services, Inc. earned 30.4% on its shareholders' money over the last year, higher than 94% of Healthcare companies in United States.
How much does Guardian Pharmacy Services, Inc. owe compared with what it owns?
Guardian Pharmacy Services, Inc. owes $0.42 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Does Guardian Pharmacy Services, Inc. pay a dividend?
No. Guardian Pharmacy Services, Inc. does not currently pay a dividend.
Is Guardian Pharmacy Services, Inc.'s revenue growing?
Revenue rose 18% in the year to Dec 2025, and grew 17% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.